Steven Cohen’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.9K Buy
+28,385
New +$45.1K ﹤0.01% 3827
2025
Q1
Sell
-508,438
Closed -$2.21M 2116
2024
Q4
$2.21M Buy
+508,438
New +$1.59M ﹤0.01% 1207
2022
Q1
Sell
-501,649
Closed -$3.02M 1203
2021
Q4
$3.02M Buy
+501,649
New +$2.99M 0.01% 764

Other funds holding CRDF

Steven Cohen's CRDF Position: Q2 2026 in Review

Steven Cohen opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 28,385 shares worth $36.9K. The stake represents ﹤0.01% of the portfolio and ranks #3827 among its holdings. This is a return to the name: Steven Cohen previously reported a position in CRDF as recently as Q4 2024.

Steven Cohen first reported a position in CRDF in Q4 2021 and has held it in 3 quarters since. The position peaked at $3.02M in Q4 2021. 104 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Steven Cohen held 28,385 shares of Cardiff Oncology worth $36.9K as of Q2 2026.
  • Cardiff Oncology was a new Steven Cohen position in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3827 holding.
  • Steven Cohen first reported a position in Cardiff Oncology in Q4 2021 and has held it in 3 quarters since.
  • Steven Cohen's Cardiff Oncology position peaked at $3.02M in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.